Optimized for the underserved: A new diagnostic test built for low-income settings

“On Wednesday, medical diagnostic device company Hemex Health officially launched Gazelle after its sickle cell disease test was given regulatory approval in India and Ghana, with other country registrations pending.”

via Devex